Covered recipient · General Payments record
MELISSA RENEE NICKOLS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2021–2024
$659.21
- Reported across 28 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $392.70 | 15 |
| Education | $13.62 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Biotech, Inc. | $98.02 | 3 |
| ABBVIE INC. | $88.66 | 4 |
| PFIZER INC. | $47.33 | 2 |
| QOL Medical, LLC | $37.01 | 1 |
| Ipsen Biopharmaceuticals, Inc | $31.63 | 1 |
| Gilead Sciences, Inc. | $29.05 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $24.80 | 1 |
| Ardelyx, Inc. | $20.82 | 1 |
| Alnylam Pharmaceuticals Inc. | $15.38 | 1 |
| Celltrion USA Inc. | $13.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.56 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107739371 | CMS |
| ABBVIE INC. | $32.50 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107739373 | CMS |
| ABBVIE INC. | $16.74 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107739375 | CMS |
| ABBVIE INC. | $17.86 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107739377 | CMS |
| Alnylam Pharmaceuticals Inc. | $15.38 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125852771 | CMS |
| Ardelyx, Inc. | $20.82 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146739488 | CMS |
| Celltrion USA Inc. | $13.62 | 05/12/2024 | Education | Undisputed | 01/23/2026 | 1075865677 | CMS |
| Gilead Sciences, Inc. | $29.05 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133714249 | CMS |
| Ipsen Biopharmaceuticals, Inc | $31.63 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1091989751 | CMS |
| Janssen Biotech, Inc. | $32.59 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078375620 | CMS |
| Janssen Biotech, Inc. | $32.76 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078375417 | CMS |
| Janssen Biotech, Inc. | $32.67 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078375457 | CMS |
| PFIZER INC. | $25.52 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131915047 | CMS |
| PFIZER INC. | $21.81 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131984095 | CMS |
| QOL Medical, LLC | $37.01 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147732826 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $24.80 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153565633 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.